Bexarotene in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bexarotene
Sponsor: Ligand Pharmaceuticals